BamSEC and AlphaSense Join Forces
Learn More

Inhibikase Therapeutics Inc.

NASDAQ: IKT    
Share price (12/20/24): $3.20    
Market cap (12/20/24): $215 million

Indentures Filter

EX-4.3
from 8-K 22 pages Form of Series B-1 Warrant to Purchase Common Stock or Pre-Funded Warrants
12/34/56
EX-4.2
from 8-K 22 pages Form of Series A-1 Warrant to Purchase Common Stock or Pre-Funded Warrants
12/34/56
EX-4.1
from 8-K 18 pages Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.6
from 8-K 2 pages Amendment to Common Stock Purchase Warrants
12/34/56
EX-4.5
from 8-K 17 pages Series D Common Stock Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56
EX-4.4
from 8-K 17 pages Series C Common Stock Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56
EX-4.3
from 8-K 17 pages Series B Common Stock Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 17 pages Series a Common Stock Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 12 pages Pre-Funded Common Stock Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56
EX-4.14
from S-1/A 17 pages Inhibikase Therapeutics, Inc. and Equiniti Trust Company, LLC, as Warrant Agent Warrant Agency Agreement Dated as of [ ] __, 2024 Warrant Agency Agreement
12/34/56
EX-4.11
from S-1/A 18 pages Common Stock Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56
EX-4.13
from S-1/A 15 pages Placement Agent Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56
EX-4.12
from S-1/A 12 pages Pre-Funded Common Stock Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56
EX-4.11
from S-1/A 16 pages Common Stock Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56
EX-4.5
from 8-K 18 pages Placement Agent Common Stock Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56
EX-4.4
from 8-K 18 pages Common Stock Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56
EX-4.3
from 8-K 19 pages Pre-Funded Common Stock Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 18 pages Common Stock Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 18 pages Pre-Funded Common Stock Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56
EX-4.2
from S-3 32 pages Inhibikase Therapeutics, Inc. Indenture Dated as of , 20___ [ ] Trustee
12/34/56